ConductScience.org, home

Paper36001024

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.

Anurag M and 38 others. Cancer Discov, 2022. Cited by 114 papers, by iCite.

Cite this record

ConductScience Library. Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Papers, record 36001024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36001024

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
PubMed
Journal
Cancer Discov
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
114
iCite
Relative citation ratio, by iCite
7.4
iCite
Revised in PubMed
2024-02-11
PubMed

Authors39

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Triple Negative Breast NeoplasmsMajor topic
ProteogenomicsMajor topic
Humans
Carboplatin
Proteomics
Antineoplastic Combined Chemotherapy Protocols
Neoadjuvant Therapy
X-ray Repair Cross Complementing Protein 1

Source PubMed

Download CSV of topics

Grants17

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U54 CA224076NCI NIH HHSUnited StatesU54CA224076PubMed and NIHNIH RePORTER
R03 OD032626NIH HHSUnited StatesR03OD032626PubMedNIH RePORTER
U24 CA271075NCI NIH HHSUnited StatesU24CA271075PubMed and NIHNIH RePORTER
U24 CA270823NCI NIH HHSUnited StatesU24CA270823PubMed and NIHNIH RePORTER
P30 CA125123NCI NIH HHSUnited StatesP30CA125123PubMedNIH RePORTER
S10 OD028671NIH HHSUnited StatesS10OD028671PubMedNIH RePORTER
U24 CA210979NCI NIH HHSUnited StatesU24CA210979PubMedNIH RePORTER
U01 CA214125NCI NIH HHSUnited StatesU01CA214125PubMed and NIHNIH RePORTER
T32 CA203690NCI NIH HHSUnited StatesT32CA203690PubMed and NIHNIH RePORTER
P50 CA186784NCI NIH HHSUnited StatesP50CA186784PubMed and NIHNIH RePORTER
U24 CA210954NCI NIH HHSUnited StatesU24CA210954PubMed and NIHNIH RePORTER
U24 CA160034NCI NIH HHSUnited StatesU24CA160034PubMed and NIHNIH RePORTER
U24 CA210986NCI NIH HHSUnited StatesU24CA210986PubMed and NIHNIH RePORTER
K12 CA167540NCI NIH HHSUnited StatesK12CA167540PubMedNIH RePORTER
U24 CA226110NCI NIH HHSUnited StatesU24CA226110PubMed and NIHNIH RePORTER
U54 CA224083NCI NIH HHSUnited StatesU54CA224083PubMed and NIHNIH RePORTER
K22 CA241113NCI NIH HHSUnited StatesK22CA241113PubMed and NIHNIH RePORTER

Download CSV of grants

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127641504A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.Cell2016https://conductscience.org/library/papers/27641504PubMed
226131740DNA Ligases I and III Support Nucleotide Excision Repair in DT40 Cells with Similar Efficiency.Photochem Photobiol2015https://conductscience.org/library/papers/26131740PubMed
310559260Long patch base excision repair with purified human proteins. DNA ligase I as patch size mediator for DNA polymerases delta and epsilon.J Biol Chem1999https://conductscience.org/library/papers/10559260PubMed
425360585BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.Mod Pathol2015https://conductscience.org/library/papers/25360585PubMed
517671126Triple-negative breast cancer: clinical features and patterns of recurrence.Clin Cancer Res2007https://conductscience.org/library/papers/17671126PubMed
619223467DNA ligase I deficiency leads to replication-dependent DNA damage and impacts cell morphology without blocking cell cycle progression.Mol Cell Biol2009https://conductscience.org/library/papers/19223467PubMed
717785706Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.J Clin Oncol2007https://conductscience.org/library/papers/17785706PubMed
829344893Profiling Tumor Infiltrating Immune Cells with CIBERSORT.Methods Mol Biol2018https://conductscience.org/library/papers/29344893PubMed
918971340High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18971340PubMed
1025907283Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer.Int J Cancer2015https://conductscience.org/library/papers/25907283PubMed
1133041185Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients.Eur J Cancer2022https://conductscience.org/library/papers/33041185PubMed
1221558518A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.JAMA2011https://conductscience.org/library/papers/21558518PubMed
131581963Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents.Cell1992https://conductscience.org/library/papers/1581963PubMed
1432509178MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells.Am J Transl Res2020https://conductscience.org/library/papers/32509178PubMed
1527836980Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction.Mol Cell Proteomics2017https://conductscience.org/library/papers/27836980PubMed
1628045625
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).
J Clin Oncol2017https://conductscience.org/library/papers/28045625PubMed
1730563849A Curated Resource for Phosphosite-specific Signature Analysis.Mol Cell Proteomics2019https://conductscience.org/library/papers/30563849PubMed
1812124343Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene.Cancer Res2002https://conductscience.org/library/papers/12124343PubMed
19782919DNA ligases of eukaryotes.FEBS Lett1976https://conductscience.org/library/papers/782919PubMed
2021527027GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.Genome Biol2011https://conductscience.org/library/papers/21527027PubMed

See all 65 referencesDownload CSV of references

Cited by81

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.

PMIDTitleJournalYearIn PapersSource
42972023Early temporal transcriptional and cytokine responses distinguish chemotherapy sensitivity in patient-derived xenograft models of triple-negative breast cancer.Oncogene2026https://conductscience.org/library/papers/42972023PubMed
42573022Proteomic Biomarker Discovery in Breast Cancer: Advances, Challenges, and Translational Prospects.J Biochem Mol Toxicol2026https://conductscience.org/library/papers/42573022PubMed
42559234CTPS1 is an unexplored vulnerability in breast and ovarian cancer.Theranostics2026https://conductscience.org/library/papers/42559234PubMed
42510676Immune-Metabolic Profiling Reveals Functional Heterogeneity Within Colorectal Cancer Consensus Molecular Subtypes.Biology (Basel)2026https://conductscience.org/library/papers/42510676PubMed
42456172LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations.Mol Cancer Ther2026https://conductscience.org/library/papers/42456172PubMed
423055863D EM uncovers mitochondrial network remodeling in residual triple negative breast cancer after conventional chemotherapy treatments.iScience2026https://conductscience.org/library/papers/42305586PubMed
42237373Proteomics in bone malignancies: from bulk profiling to single-cell and ultra-low-input technologies.J Transl Med2026https://conductscience.org/library/papers/42237373PubMed
42219424Discovery of a novel dual-target modulator of ULK1 and ERK1/2 that suppresses triple-negative breast cancer progression and metastasis via the Exo70/Cav-1/MMPs axis.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42219424PubMed
42140958Identification and functional validation of EPS15L1 as a key driver of triple-negative breast cancer.NPJ Breast Cancer2026https://conductscience.org/library/papers/42140958PubMed
42074251Identification and Integration of LRG1-Induced Differentially Expressed Gene (DEG) Hub Profiles in Breast Cancer Cells.Int J Mol Sci2026https://conductscience.org/library/papers/42074251PubMed
42056559Crosstalk between integrin signaling and NAD⁺ biosynthetic pathways promotes glycolysis, proliferation, survival, and tumor growth in triple-negative breast cancer.Oncogene2026https://conductscience.org/library/papers/42056559PubMed
42034977MultiOmicsXplorer, a tool to browse, access and analyse multi-omics data.BMC Bioinformatics2026https://conductscience.org/library/papers/42034977PubMed
41977343Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer.Int J Mol Sci2026https://conductscience.org/library/papers/41977343PubMed
41975515Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer.Genome Biol2026https://conductscience.org/library/papers/41975515PubMed
41810343Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer.World J Clin Oncol2026https://conductscience.org/library/papers/41810343PubMed
41604018Deciphering RNA and protein expression discordance identifies TOP2A as a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.Discov Oncol2026https://conductscience.org/library/papers/41604018PubMed
41540000Bisphosphate nucleotidase 1 promotes progression and docetaxel resistance in triple-negative breast cancer via STUB1-mediated destabilization of LIMA1.Cell Death Dis2026https://conductscience.org/library/papers/41540000PubMed
41465346Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter.Int J Mol Sci2025https://conductscience.org/library/papers/41465346PubMed
41310667Targeting the MAGED2-TRIM28-FLNC axis overcomes chemoresistance in TNBC via EMT suppression.Cell Commun Signal2025https://conductscience.org/library/papers/41310667PubMed
41279138Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer.bioRxiv2025https://conductscience.org/library/papers/41279138PubMed

See all 81 cited byDownload CSV of cited by

Genes55

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACADS35PubTator's text mininghttps://conductscience.org/library/genes/35NCBI Gene
ACAT138PubTator's text mininghttps://conductscience.org/library/genes/38NCBI Gene
ACO250PubTator's text mininghttps://conductscience.org/library/genes/50NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALDH6A14329PubTator's text mininghttps://conductscience.org/library/genes/4329NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
BCKDHB594PubTator's text mininghttps://conductscience.org/library/genes/594NCBI Gene
BCL3602PubTator's text mininghttps://conductscience.org/library/genes/602NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CDC78317PubTator's text mininghttps://conductscience.org/library/genes/8317NCBI Gene
CDK1983PubTator's text mininghttps://conductscience.org/library/genes/983NCBI Gene
CDK1251755PubTator's text mininghttps://conductscience.org/library/genes/51755NCBI Gene
CDK21017PubTator's text mininghttps://conductscience.org/library/genes/1017NCBI Gene
CDK41019PubTator's text mininghttps://conductscience.org/library/genes/1019NCBI Gene
CPNE38895PubTator's text mininghttps://conductscience.org/library/genes/8895NCBI Gene
CRAT1384PubTator's text mininghttps://conductscience.org/library/genes/1384NCBI Gene
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
DBT1629PubTator's text mininghttps://conductscience.org/library/genes/1629NCBI Gene

See all 55 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36001024

GET https://conductscience.org/api/papers/v1/36001024/authors?page=2